Table 1 Characteristics of the nine locoregional irradiations.
Patient | Sites | CTVcc | PTVcc | Dose | Technique | Grade ≥ 2 acute toxicity | Palbociclib suspension due to toxicity |
|---|---|---|---|---|---|---|---|
1 | Left thoracic wall + left L1–L4 and IP | 223 | 392 | 50 Gy (2 Gy/f) | Tomo | 0 | 0 |
2 | Right thoracic wall + right L2–L4, IP, and IMN | 362 | 669 | 50 Gy (2 Gy/f) | VMAT | Neutropenia | 0 |
3 | Left breast + left L1–L4 and IP | 566 | 820 | 50 Gy (2 Gy/f) | Tomo | 0 | 0 |
4 | Right breast + right L1–L4 and IP SIB | 1082 | 1285 | 50.4 Gy (1.8 Gy/f) SIB: up to 64.4 Gy (2.3 Gy/f) | Tomo | 0 | 0 |
5 | Right thoracic wall + right L1–L4 and IP | 395 | 725 | 50 Gy (2 Gy/f) | Tomo | 0 | 0 |
6 | Right thoracic wall + right L1–L4 and IP | 511 | 805 | 50 Gy (2 Gy/f) | Tomo | 0 | 0 |
7 | Left thoracic wall + left L2–L4 and IP | 533 | 778 | 50 Gy (2 Gy/f) | Tomo | 0 | 0 |
8 | Left breast + left L2–L4 and IP SIB | 1355 | 1607 | 50.4 Gy (1.8 Gy/f) SIB: up to 64.4 Gy (2.3 Gy/f) | VMAT | Dermatitis, neutropenia and dysphagia | 1 |
9 | Bilateral thoracic walls + bilateral L1–L4 and IP | 1019 | 1607 | 50 Gy (2 Gy/f) | Tomo | Dermatitis, neutropenia and pain | 1 |
